TITLE:
Ultraviolet Light Therapy for Systemic Lupus Erythematosus

CONDITION:
Systemic Lupus Erythematosus

INTERVENTION:
ultraviolet A-1 light treatment

SUMMARY:

      OBJECTIVES:

      I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus
      erythematosus and normal controls.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE:

      Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the
      lowest dose or frequency required to maintain a response. The dose and frequency are
      progressively decreased over the next 9 weeks.
    

ELIGIBILITY:
Gender: All
Age: 15 Years to 70 Years
Criteria:

        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics--

        Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American
        Rheumatism Association criteria and normal controls

        --Prior/Concurrent Therapy--

        No requirement for tetracycline or other photosensitizing drugs
      
